查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1291348

基因治疗市场：2023-2028年全球行业趋势、份额、规模、增长、机会和预测

Gene Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3个工作天内

价格

2022年，全球基因治疗市场规模达到44亿美元。展望未来，IMARC集团预计，到2028年，市场规模将达到109亿美元，在2023-2028年期间呈现15.39%的增长率（CAGR）。遗传性疾病和获得性疾病的发病率越来越高；医院、诊所和疗养院的建设越来越多；以及新的基因疗法的普及，为阿片类药物提供了更安全、无成瘾性的替代品，这些都是推动市场的一些关键因素。

慢性病的发生率上升促进了市场增长

各种慢性病在群众中的发病率越来越高，这是推动基因治疗市场增长的关键因素之一。除此之外，由于采用不健康的生活方式，各种慢性病的发生，如心血管并发症、糖尿病、甲状腺炎和肥胖症，也促进了市场的增长。此外，大众中癌症病例的增加，以及对有效的肿瘤治疗需求的增长，正在提供一个有利的市场前景。此外，由于过度吸烟的习惯，慢性肺部疾病的发生率越来越高，这也促进了基因治疗市场的增长。

报告中涵盖了竞争分析，如市场结构、主要参与者的市场份额、参与者定位、顶尖的制胜战略、竞争仪表板和公司评估象限。此外，还提供了所有主要公司的详细简介。由于存在大量的全球和区域参与者，基因治疗市场的结构是适度分散的。由于需要高额的资本投资、严格的政府政策，市场上新进入者的数量是适中的，而且产品差异化率很低。

什么是基因治疗？

基因治疗是一种通过修改变异基因的表达或改变活细胞的生物特性来预防疾病进展的技术，用于治疗。它包括不同的产品，如病毒载体、细菌载体、质粒脱氧核糖核酸（DNA）、人类基因编辑技术和病人衍生的细胞基因治疗。它涉及将一个健康的基因引入个人的基因组，以修复导致遗传疾病的突变。它包括各种疗法，如体外、体内和原位基因疗法。基因治疗的功能是通过基因抑制、基因增强，并最终杀死致病细胞。它可以治愈某些药物无法预防的疾病，并有可能永久地摆脱疾病症状。它还能提高身体对抗各种疾病的能力，如癌症、糖尿病、血友病、囊性纤维化、心脏病和获得性免疫缺陷综合征（AIDS）。此外，由于基因疗法不像其他药物那样需要多次用药，其需求在世界各地不断增加。

COVID-19的影响：

冠状病毒的爆发严重扰乱了基因治疗市场，影响了各生物制药公司的业绩。一些基因治疗公司由于其复杂的制造和交付系统以及筹资模式，面临着大量的复杂问题。治疗的制造和交付、研究和临床开发以及商业运作受到大流行病的负面影响，这导致了基因治疗市场增长的中断。此外，支持基因治疗产品的制造和开发的供应链需要受控和复杂的环境。供应链受到了封锁和对通过道路移动的限制的严重影响。此外，有几家公司报告说，由于COVID-19的爆发，经营出现了延误或完全停止。

基因治疗市场趋势：

目前，对基因治疗的需求不断增长，因为它能有效地治愈各种危急和威胁生命的疾病，是积极影响市场的主要因素之一。除此之外，遗传性疾病和后天性疾病在大众中的流行率上升，也推动了市场的增长。此外，世界各地越来越多的医院、诊所和疗养院的建设，为病人提供高质量的医疗保健服务，也促进了市场的增长。除此之外，新的基因疗法的普及，为治疗广泛的慢性疼痛疾病，如下背痛和罕见的神经性疼痛疾病，提供了一个更安全和无成瘾性的替代品，正在提供一个有利的市场前景。

目录

第一章：前言

第二章：范围和方法

  • 研究的目标
  • 利益相关者
  • 数据来源
    • 主要来源
    • 二级来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球基因治疗市场

  • 市场概况
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：按基因类型分類的市场

  • 抗原
    • 市场趋势
    • 市场预测
  • 细胞因子
    • 市场趋势
    • 市场预测
  • 肿瘤抑制因子
    • 市场趋势
    • 市场预测
  • 自杀基因
    • 市场趋势
    • 市场预测
  • 缺陷
    • 市场趋势
    • 市场预测
  • 增长因素
    • 市场趋势
    • 市场预测
  • 受体
    • 市场趋势
    • 市场预测
  • 其他
    • 市场趋势
    • 市场预测

第7章 ：按载体类型分類的市场

  • 病毒载体
    • 市场趋势
    • 关键部分
      • 腺病毒
      • 慢病毒
      • 逆转录病毒
      • 腺相关病毒
      • 单纯疱疹病毒
      • 痘病毒
      • 疫苗病毒
      • 其他病毒
    • 市场预测
  • 非病毒性技术
    • 市场趋势
    • 关键领域
      • 裸体和质粒载体
      • 基因枪
      • 电穿孔
      • 脂质感染
      • 其他领域
    • 市场预测

第8章：按给药方式分類的市场

  • 体内基因治疗
    • 市场趋势
    • 市场预测
  • 体外基因治疗
    • 市场趋势
    • 市场预测

第九章：按应用分類的市场

  • 肿瘤性疾病
    • 市场趋势
    • 市场预测
  • 罕见病
    • 市场趋势
    • 市场预测
  • 心血管疾病
    • 市场趋势
    • 市场预测
  • 神经系统疾病
    • 市场趋势
    • 市场预测
  • 传染性疾病
    • 市场趋势
    • 市场预测
  • 其他
    • 市场趋势
    • 市场预测

第十章：按地区分類的市场

  • 北美洲
    • 美国
      • 市场趋势
      • 市场预测
    • 加拿大
      • 市场趋势
      • 市场预测
  • 亚太地区
    • 中国
      • 市场趋势
      • 市场预测
    • 日本
      • 市场趋势
      • 市场预测
    • 印度
      • 市场趋势
      • 市场预测
    • 韩国
      • 市场趋势
      • 市场预测
    • 澳大利亚
      • 市场趋势
      • 市场预测
    • 印尼
      • 市场趋势
      • 市场预测
    • 其他国家
      • 市场趋势
      • 市场预测
  • 欧洲
    • 德国
      • 市场趋势
      • 市场预测
    • 法国
      • 市场趋势
      • 市场预测
    • 英国
      • 市场趋势
      • 市场预测
    • 意大利
      • 市场趋势
      • 市场预测
    • 西班牙
      • 市场趋势
      • 市场预测
    • 俄罗斯
      • 市场趋势
      • 市场预测
    • 其他国家
      • 市场趋势
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场趋势
      • 市场预测
    • 墨西哥
      • 市场趋势
      • 市场预测
    • 其他国家
      • 市场趋势
      • 市场预测
  • 中东和非洲
    • 市场趋势
    • 按国家分類的市场
    • 市场预测

第十一章 ：SWOT分析

  • 概述
  • 优势
  • 劣势
  • 机会
  • 威胁

第十二章 ：价值链分析

第十三章 ：波特斯五力分析

  • 概述
  • 买方的讨价还价能力
  • 供应商的讨价还价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第十四章：价格分析

第十五章 ：竞争格局

  • 市场结构
  • 主要参与者
  • 主要参与者的概况
    • Abeona Therapeutics Inc.
    • Adaptimmune Therapeutics plc
    • Adverum Biotechnologies Inc.
    • Amgen Inc.
    • Astellas Pharma Inc.
    • Biogen Inc.
    • Bluebird Bio Inc.
    • Mustang Bio Inc. (Fortress Biotech Inc.)
    • Novartis AG
    • Orchard Therapeutics plc
    • UniQure N.V.
    • Voyager Therapeutics Inc.
Product Code: SR112023A5026

The global gene therapy market size reached US$ 4.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.9 Billion by 2028, exhibiting a growth rate (CAGR) of 15.39% during 2023-2028. The growing prevalence of inherited diseases and acquired disorders; increasing construction of hospitals, clinics, and nursing homes; and rising popularity of new gene therapy that offers a safer, non-addictive alternative to opioids represent some of the key factors driving the market.

Rising Occurrence of Chronic Diseases Augmenting Market Growth

The increasing prevalence of various chronic diseases among the masses represents one of the key factors propelling the growth of the gene therapy market. Besides this, the occurrence of various chronic diseases, such as cardiovascular complications, diabetes, thyroiditis, and obesity, due to the adoption of unhealthy lifestyle patterns is contributing to the growth of the market. Moreover, rising cases of cancer among the masses, along with the growing demand for effective oncology treatment, is offering a favorable market outlook. Furthermore, the increasing occurrence of chronic lung diseases due to excessive smoking habits is bolstering the growth of the gene therapy market.

Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. The structure of the gene therapy market is moderately fragmented due to the presence of a large number of global and regional players. The volume of new entrants in the market is moderate due to the requirement for high capital investments, stringent government policies, and the rate of product differentiation is low.

What is Gene Therapy?

Gene therapy is a technique for preventing disease progression by modifying the expression of mutated genes or altering the biological properties of living cells for therapeutic use. It comprises different products, such as viral vectors, bacterial vectors, plasmid deoxyribonucleic acid (DNA), human gene-editing technology, and patient-derived cellular gene therapy. It involves the introduction of a healthy gene into the genome of an individual to repair a mutation that is causing a genetic disorder. It consists of various therapies, such as ex vivo, in vivo, and in situ gene therapy. Gene therapy functions via gene inhibition, gene augmentation, and ultimately killing the disease-causing cells. It can cure certain diseases which no medications can prevent and has the potential to get rid of disease symptoms permanently. It also improves the ability of the body to fight against a wide variety of diseases, such as cancer, diabetes, hemophilia, cystic fibrosis, heart disease, and acquired immunodeficiency syndrome (AIDS). Furthermore, as gene therapy does not require multiple doses like other medications, its demand is increasing around the world.

COVID-19 Impact:

The outbreak of coronavirus severely disrupted the gene therapy market and affected the performance of various biopharmaceutical companies. Some gene therapy companies faced an immense number of complications due to their complicated manufacturing and delivery systems and funding models. The manufacture and delivery of treatment, research and clinical development, and commercial operations were negatively impacted by the pandemic, which resulted in a disruption in the growth of the gene therapy market. In addition, the supply chains that support the manufacturing and development of gene therapy products require controlled and complex settings. The supply chain was severely impacted by lockdowns and restrictions imposed on movement via roads. Furthermore, several companies reported delays or complete halts in operations due to the outbreak of COVID-19.

Gene Therapy Market Trends:

At present, the growing demand for gene therapy, as it is effective in curing various critical and life-threatening diseases, represents one of the primary factors influencing the market positively. Besides this, the rising prevalence of inherited diseases and acquired disorders among the masses is propelling the growth of the market. In addition, the increasing construction of hospitals, clinics, and nursing homes around the world to provide quality healthcare services to patients is contributing to the growth of the market. Apart from this, the rising popularity of new gene therapy that offers a safer and non-addictive alternative to opioids in treating a broad range of chronic pain conditions, such as lower back pain and rare neuropathic pain disorders, is offering a favorable market outlook.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global gene therapy market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on gene type, vector type, delivery method and application.

Gene Type Insights:

Antigen

Cytokine

Tumor Suppressor

Suicide Gene

Deficiency

Growth Factors

Receptors

Others

The report has provided a detailed breakup and analysis of the gene therapy market based on the gene type. This includes antigen, cytokine, tumor suppressor, suicide gene, deficiency, growth factors, receptors, and others.

Vector Type Insights:

Viral Vector

Adenoviruses

Lentiviruses

Retroviruses

Adeno-Associated Virus

Herpes Simplex Virus

Poxvirus

Vaccinia Virus

Others

Non-Viral Techniques

Naked and Plasmid Vectors

Gene Gun

Electroporation

Lipofection

Others

A detailed breakup and analysis of the gene therapy market based on the vector type has also been provided in the report. This includes viral vector (adenoviruses, lentiviruses, retroviruses, adeno-associated virus, herpes simplex virus, poxvirus, vaccinia virus, and others) and non-viral techniques (naked and plasmid vectors, gene gun, electroporation, lipofection, and others). According to the report, viral vector (adenoviruses, lentiviruses, retroviruses, adeno-associated virus, herpes simplex virus, poxvirus, vaccinia virus, and others) accounted for the largest market share as it is highly efficient in mitigating the impacts of infectious diseases and viruses. In addition, the rising utilization of viral vectors as they are easy to handle and modify is propelling the growth of the respective segment.

Delivery Method Insights:

In-Vivo Gene Therapy

Ex-Vivo Gene Therapy

A detailed breakup and analysis of the gene therapy market based on the delivery method has also been provided in the report. This includes in-vivo gene therapy and ex-vivo gene therapy.

Application Insights:

Oncological Disorders

Rare Diseases

Cardiovascular Diseases

Neurological Disorders

Infectious Disease

Others

A detailed breakup and analysis of the gene therapy market based on the application has also been provided in the report. This includes oncological disorders, rare diseases, cardiovascular diseases, neurological disorders, infectious disease, and others. According to the report, oncological disorders accounted for the largest market share due to increasing occurrence of cancer among the masses. Apart from this, the rising employment of gene therapy in cancer treatment as it provides remarkable efficacy is bolstering the growth of the market.

Regional Insights:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for gene therapy. Some of the factors driving the North America gene therapy market included the rising awareness about the benefits of gene therapy in treating various chronic diseases and the increasing expenditure in research and development (R&D) activities to develop effective gene therapies is propelling the market growth. In addition, the growing construction of various healthcare facilities to provide quality treatment to patients is propelling the growth of the market.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global gene therapy market. Some of the companies covered in the report include:

Abeona Therapeutics Inc.

Adaptimmune Therapeutics plc

Adverum Biotechnologies Inc.

Amgen Inc.

Astellas Pharma Inc.

Biogen Inc.

Bluebird Bio Inc.

Mustang Bio Inc. (Fortress Biotech Inc.)

Novartis AG

Orchard Therapeutics plc

UniQure N.V.

Voyager Therapeutics Inc.

Please note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

1. What was the size of the global gene therapy market in 2022?

2. What is the expected growth rate of the global gene therapy market during 2023-2028?

3. What are the key factors driving the global gene therapy market?

4. What has been the impact of COVID-19 on the global gene therapy market?

5. What is the breakup of the global gene therapy market based on the vector type?

6. What is the breakup of the global gene therapy market based on the application?

7. What are the key regions in the global gene therapy market?

8. Who are the key players/companies in the global gene therapy market?

Table of Contents

1   Preface

2   Scope and Methodology

  • 2.1  Objectives of the Study
  • 2.2  Stakeholders
  • 2.3  Data Sources
    • 2.3.1  Primary Sources
    • 2.3.2  Secondary Sources
  • 2.4  Market Estimation
    • 2.4.1  Bottom-Up Approach
    • 2.4.2  Top-Down Approach
  • 2.5  Forecasting Methodology

3   Executive Summary

4   Introduction

  • 4.1  Overview
  • 4.2  Key Industry Trends

5   Global Gene Therapy Market

  • 5.1  Market Overview
  • 5.2  Market Performance
  • 5.3  Impact of COVID-19
  • 5.4  Market Forecast

6   Market Breakup by Gene Type

  • 6.1  Antigen
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2  Cytokine
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3  Tumor Suppressor
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4  Suicide Gene
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5  Deficiency
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6  Growth Factors
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7  Receptors
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8  Others
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast

7   Market Breakup by Vector Type

  • 7.1  Viral Vector
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Adenoviruses
      • 7.1.2.2 Lentiviruses
      • 7.1.2.3 Retroviruses
      • 7.1.2.4 Adeno-Associated Virus
      • 7.1.2.5 Herpes Simplex Virus
      • 7.1.2.6 Poxvirus
      • 7.1.2.7 Vaccinia Virus
      • 7.1.2.8 Others
    • 7.1.3 Market Forecast
  • 7.2  Non-Viral Techniques
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Naked and Plasmid Vectors
      • 7.2.2.2 Gene Gun
      • 7.2.2.3 Electroporation
      • 7.2.2.4 Lipofection
      • 7.2.2.5 Others
    • 7.2.3 Market Forecast

8   Market Breakup by Delivery Method

  • 8.1  In-Vivo Gene Therapy
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2  Ex-Vivo Gene Therapy
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9   Market Breakup by Application

  • 9.1  Oncological Disorders
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2  Rare Diseases
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3  Cardiovascular Diseases
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4  Neurological Disorders
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5  Infectious Disease
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast
  • 9.6  Others
    • 9.6.1 Market Trends
    • 9.6.2 Market Forecast

10  Market Breakup by Region

  • 10.1  North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2  Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3  Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4  Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5  Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11  SWOT Analysis

  • 11.1  Overview
  • 11.2  Strengths
  • 11.3  Weaknesses
  • 11.4  Opportunities
  • 11.5  Threats

12  Value Chain Analysis

13  Porters Five Forces Analysis

  • 13.1  Overview
  • 13.2  Bargaining Power of Buyers
  • 13.3  Bargaining Power of Suppliers
  • 13.4  Degree of Competition
  • 13.5  Threat of New Entrants
  • 13.6  Threat of Substitutes

14  Price Analysis

15  Competitive Landscape

  • 15.1  Market Structure
  • 15.2  Key Players
  • 15.3  Profiles of Key Players
    • 15.3.1  Abeona Therapeutics Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2  Adaptimmune Therapeutics plc
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3  Adverum Biotechnologies Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
    • 15.3.4  Amgen Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5  Astellas Pharma Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6  Biogen Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7  Bluebird Bio Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8  Mustang Bio Inc. (Fortress Biotech Inc.)
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9  Novartis AG
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10  Orchard Therapeutics plc
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
    • 15.3.11  UniQure N.V.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
    • 15.3.12  Voyager Therapeutics Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials

List of Figures

  • Figure 1: Global: Gene Therapy Market: Major Drivers and Challenges
  • Figure 2: Global: Gene Therapy Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Gene Therapy Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Gene Therapy Market: Breakup by Gene Type (in %), 2022
  • Figure 5: Global: Gene Therapy Market: Breakup by Vector Type (in %), 2022
  • Figure 6: Global: Gene Therapy Market: Breakup by Delivery Method (in %), 2022
  • Figure 7: Global: Gene Therapy Market: Breakup by Application (in %), 2022
  • Figure 8: Global: Gene Therapy Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Gene Therapy (Antigen) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Gene Therapy (Antigen) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Gene Therapy (Cytokine) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Gene Therapy (Cytokine) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Gene Therapy (Tumor Suppressor) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Gene Therapy (Tumor Suppressor) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Gene Therapy (Suicide Gene) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Gene Therapy (Suicide Gene) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Gene Therapy (Deficiency) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Gene Therapy (Deficiency) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Gene Therapy (Growth Factors) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Gene Therapy (Growth Factors) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Gene Therapy (Receptors) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Gene Therapy (Receptors) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Gene Therapy (Other Gene Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Gene Therapy (Other Gene Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Gene Therapy (Viral Vector) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Gene Therapy (Viral Vector) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Gene Therapy (Non-Viral Techniques) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Gene Therapy (Non-Viral Techniques) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Gene Therapy (In-Vivo Gene Therapy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Gene Therapy (In-Vivo Gene Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Gene Therapy (Ex-Vivo Gene Therapy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Gene Therapy (Ex-Vivo Gene Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Gene Therapy (Oncological Disorders) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Gene Therapy (Oncological Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Gene Therapy (Rare Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Gene Therapy (Rare Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Global: Gene Therapy (Cardiovascular Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Global: Gene Therapy (Cardiovascular Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Global: Gene Therapy (Neurological Disorders) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Global: Gene Therapy (Neurological Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Global: Gene Therapy (Infectious Disease) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Global: Gene Therapy (Infectious Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Global: Gene Therapy (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Global: Gene Therapy (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: North America: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: North America: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: United States: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: United States: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Canada: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Canada: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Asia-Pacific: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Asia-Pacific: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: China: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: China: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Japan: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Japan: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: India: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: India: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: South Korea: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: South Korea: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Australia: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Australia: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Indonesia: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Indonesia: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Others: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Others: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Europe: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Europe: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Germany: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Germany: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: France: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: France: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: United Kingdom: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: United Kingdom: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Italy: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Italy: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Spain: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Spain: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Russia: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Russia: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Others: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Others: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Latin America: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Latin America: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Brazil: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 86: Brazil: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 87: Mexico: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 88: Mexico: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 89: Others: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 90: Others: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 91: Middle East and Africa: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 92: Middle East and Africa: Gene Therapy Market: Breakup by Country (in %), 2022
  • Figure 93: Middle East and Africa: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 94: Global: Gene Therapy Industry: SWOT Analysis
  • Figure 95: Global: Gene Therapy Industry: Value Chain Analysis
  • Figure 96: Global: Gene Therapy Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Gene Therapy Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Gene Therapy Market Forecast: Breakup by Gene Type (in Million US$), 2023-2028
  • Table 3: Global: Gene Therapy Market Forecast: Breakup by Vector Type (in Million US$), 2023-2028
  • Table 4: Global: Gene Therapy Market Forecast: Breakup by Delivery Method (in Million US$), 2023-2028
  • Table 5: Global: Gene Therapy Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 6: Global: Gene Therapy Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Gene Therapy Market: Competitive Structure
  • Table 8: Global: Gene Therapy Market: Key Players